@misc{10481/76701,
year = {2022},
month = {7},
url = {http://hdl.handle.net/10481/76701},
abstract = {Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease caused by an interaction between genetic,
immune and epidermal barrier factors. Several treatments can be used to treat this disease but there are patients that do
not respond to actual drugs. So, there is a need to develop effective therapies for AD. Mesenchymal stem cells (MSCs) are
non-hematopoietic multipotent adult progenitor cells with immunomodulatory power and self-regenerating capacity to
repair tissue damage, so they could be a potential effective treatment for AD. MSCs-Conditioned Medium (CM) and
MSCs-exosomes are cell-free preparation with molecules secreted by stem cells that could be also beneficial for AD.
This viewpoint reviews the actual development of MSCs, MSCs-CM and MSCs-exosomes for treating patients with AD.},
publisher = {Tech Science},
keywords = {Atopic dermatitis},
keywords = {Conditioned medium},
keywords = {Dermatology},
keywords = {Mesenchymal stem cells},
keywords = {Stem cells},
title = {Mesenchymal stem cells and cell-free preparations for treating atopic dermatitis},
doi = {10.32604/biocell.2022.021399},
author = {Montero Vílchez, Trinidad and Sánchez Díaz, Manuel and Montero Vílchez, Carolina and Sierra Sánchez, Álvaro and Arias Santiago, Salvador Antonio},
}